Shares of Catalyst Pharmaceuticals Inc. outperform competitors in a strong trading day

by

Shares of Catalyst Pharmaceuticals Inc. CPRX,
+ 0.70%
rose 0.70% higher to $ 4.31 on Thursday in what turned out to be a tough stock market trading session with the NASDAQ Composite Index COMP
-0.72%
down 0.72% to 13,865.36 and Dow Jones Industrial Average DJIA,
-0.38%
decreasing by 0.38% to 31,493.34. This was the second consecutive day of earnings of the action. Catalyst Pharmaceuticals Inc. closed at $ 0.97 in addition to the 52-week ($ 5.28) high the company reached on Feb. 20.

The action surpassed some of its competitors on Thursday, such as Johnson & Johnson JNJ,
+ 0.05%
rose 0.05% to $ 165.74, Pfizer Inc. PFE,
-0.95%
fell 0.95% to $ 34.56, and Abbott Laboratories ABT,
-1.44%
fell 1.44% to $ 125.41. The trading volume (1.6 M) remained at 394,618 below the average volume of 50 days, of 2.0 M.

Editor’s note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See the terms of use of our market data.

.Source